Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Rev Sci Instrum ; 86(2): 026102, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25725895

ABSTRACT

This paper describes design and characterization of a digitally controlled double oven system. This allows setting the turnover point of crystal oscillators automatically. Developed for metrological purposes of active phase noise measurements, this type of thermostat with a crystal oscillator is an ultra-stable digitally controlled oven crystal oscillator.

2.
Oncogene ; 30(49): 4887-900, 2011 Dec 08.
Article in English | MEDLINE | ID: mdl-21685937

ABSTRACT

Aberrant expression of Secreted Protein Acidic and Rich in Cysteine (SPARC)/osteonectin has been associated with an invasive tumor cell phenotype and poor outcome in human melanomas. Although it is known that SPARC controls melanoma tumorigenesis, the precise role of SPARC in melanoma cell survival is still unclear. Here, we show that SPARC has a cell-autonomous survival activity, which requires Akt-dependent regulation of p53. Suppression of SPARC by RNA interference in several human melanoma cells and xenografted A375 tumors triggers apoptotic cell death through the mitochondrial intrinsic pathway and activation of caspase-3. Cell death induced by depletion of SPARC is dependent on p53 and induction of Bax, and results in the generation of ROS. Stabilization of p53 in SPARC-depleted cells is associated with a decrease in Akt-mediated activating phosphorylation of MDM2. Inhibition of Akt signaling pathway is important for the observed changes as overexpression of constitutively active Akt protects cells against apoptosis induced by SPARC depletion. Conversely, increased expression of SPARC stimulates Akt and MDM2 phosphorylation, thus facilitating p53 degradation. Finally, we show that overexpression of SPARC renders cells more resistant to the p53-mediated cytotoxic effects of the DNA-damaging drug actinomycin-D. Our study indicates that SPARC functions through activation of Akt and MDM2 to limit p53 levels and that acquired expression of SPARC during melanoma development would confer survival advantages through suppression of p53-dependent apoptotic pathways.


Subject(s)
Melanoma/pathology , Osteonectin/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-mdm2/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Dactinomycin/pharmacology , Gene Knockdown Techniques , Humans , Melanoma/genetics , Melanoma/metabolism , Mice , Osteonectin/deficiency , Osteonectin/genetics , Oxidative Stress/drug effects , Phosphorylation/drug effects , Protein Binding/drug effects , RNA Interference , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Time Factors , Up-Regulation/drug effects , bcl-2-Associated X Protein/metabolism
3.
EMBO J ; 19(12): 2900-10, 2000 Jun 15.
Article in English | MEDLINE | ID: mdl-10856235

ABSTRACT

In melanocytes and melanoma cells, cAMP activates extracellular signal-regulated kinases (ERKs) and MEK-1 by an unknown mechanism. We demonstrate that B-Raf is activated by cAMP in melanocytes. A dominant-negative mutant of B-Raf, but not of Raf-1, blocked the cAMP-induced activation of ERK, indicating that B-Raf is the MEK-1 upstream regulator mediating this cAMP effect. Studies using Clostridium sordelii lethal toxin and Clostridium difficile toxin B have suggested that Rap-1 or Ras might transduce cAMP action. We show that Ras, but not Rap-1, is activated cell-specifically and mediates the cAMP-dependent activation of ERKs, while Rap-1 is not involved in this process in melanocytes. Our results suggest a novel, cell-specific mechanism involving Ras small GTPase and B-Raf kinase as mediators of ERK activation by cAMP. Also, in melanocytes, Ras or ERK activation by cAMP is not mediated through protein kinase A activation. Neither the Ras exchange factor, Son of sevenless (SOS), nor the cAMP-responsive Rap-1 exchange factor, Epac, participate in the cAMP-dependent activation of Ras. These findings suggest the existence of a melanocyte-specific Ras exchange factor directly regulated by cAMP.


Subject(s)
Cyclic AMP/metabolism , MAP Kinase Signaling System , Melanocytes/metabolism , Mitogen-Activated Protein Kinases/metabolism , ras Proteins/metabolism , Animals , Cells, Cultured , Cyclic AMP-Dependent Protein Kinases/metabolism , Enzyme Activation , Guanine Nucleotide Exchange Factors/genetics , Guanine Nucleotide Exchange Factors/metabolism , MAP Kinase Kinase Kinases/metabolism , Melanoma, Experimental , Mice , Models, Biological , PC12 Cells , Proto-Oncogene Proteins c-raf/metabolism , Rats , Son of Sevenless Proteins/genetics , Son of Sevenless Proteins/metabolism , ras Proteins/genetics
4.
Mol Endocrinol ; 14(3): 449-56, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10707962

ABSTRACT

Microphthalmia gene encodes a basic helix-loop-helix-leucine zipper (bHLH-Zip) transcription factor involved in the development of the melanocyte lineage and plays a key role in the transcriptional regulation of the melanogenic enzymes, tyrosinase and TyrpI. Recently, we have shown that Microphthalmia mediates the melanogenic effects elicited by alphaMSH that up-regulates the expression of tyrosinase through the activation of the cAMP pathway. Therefore, Microphthalmia appears as a principal gene in melanocyte development and functioning. Among the transcription factors of the bHLH-Zip family, TFE3 and TFEB show a remarkably elevated homology with Microphthalmia. These observations prompted us to investigate the role of TFE3 and TFEB in the regulation of tyrosinase and TyrpI gene transcription. We show in this report that overexpression of TFE3 stimulates the tyrosinase and TyrpI promoter activities, while TFEB acts only on the TyrpI promoter. TFE3 and TFEB elicit their effects mainly through the binding to Mbox (AGTCATGTGCT) and Ebox motifs (CATGTG) of tyrosinase and TyrpI promoters. In B16 melanoma cells, the high basal expression of TFE3 is down-regulated by forskolin and by alphaMSH. Interestingly, endogenous TFE3 cannot bind as homodimers to the Mbox, and we did not detect TFE3/Mi heterodimers. According to these data, TFE3 is clearly endowed with the capacity to regulate tyrosinase and TyrpI gene expression. However, TFE3 binding to the melanogenic gene promoters is hindered, thereby preventing its potential melanogenic action. In specific physiological or pathological conditions, the recovery of its binding function would make TFE3 an important element in melanogenesis regulation.


Subject(s)
DNA-Binding Proteins/physiology , Membrane Glycoproteins , Monophenol Monooxygenase/metabolism , Oxidoreductases , Proteins/metabolism , Transcription Factors/physiology , Transcriptional Activation , 3T3 Cells , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Colforsin/pharmacology , Cyclic AMP/physiology , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Dimerization , Gene Expression Regulation , HeLa Cells , Helix-Loop-Helix Motifs/genetics , Helix-Loop-Helix Motifs/physiology , Humans , Keratinocytes/drug effects , Keratinocytes/metabolism , Leucine Zippers/genetics , Leucine Zippers/physiology , Melanins/metabolism , Melanocytes/drug effects , Melanocytes/metabolism , Melanoma, Experimental/pathology , Mice , Microphthalmia-Associated Transcription Factor , Promoter Regions, Genetic , Recombinant Fusion Proteins/physiology , Second Messenger Systems/drug effects , Sequence Deletion , Sequence Homology, Nucleic Acid , Transcription Factors/chemistry , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism , alpha-MSH/physiology
5.
J Cell Biol ; 142(3): 827-35, 1998 Aug 10.
Article in English | MEDLINE | ID: mdl-9700169

ABSTRACT

Melanocyte differentiation characterized by an increased melanogenesis, is stimulated by alpha-melanocyte-stimulating hormone through activation of the cAMP pathway. During this process, the expression of tyrosinase, the enzyme that controls melanin synthesis is upregulated. We previously showed that cAMP regulates transcription of the tyrosinase gene through a CATGTG motif that binds microphthalmia a transcription factor involved in melanocyte survival. Further, microphthalmia stimulates the transcriptional activity of the tyrosinase promoter and cAMP increases the binding of microphthalmia to the CATGTG motif. These observations led us to hypothesize that microphthalmia mediates the effect of cAMP on the expression of tyrosinase. The present study was designed to elucidate the mechanism by which cAMP regulates microphthalmia function and to prove our former hypothesis, suggesting that microphthalmia is a key component in cAMP-induced melanogenesis. First, we showed that cAMP upregulates the transcription of microphthalmia gene through a classical cAMP response element that is functional only in melanocytes. Then, using a dominant-negative mutant of microphthalmia, we demonstrated that microphthalmia is required for the cAMP effect on tyrosinase promoter. These findings disclose the mechanism by which cAMP stimulates tyrosinase expression and melanogenesis and emphasize the critical role of microphthalmia as signal transducer in cAMP-induced melanogenesis and pigment cell differentiation.


Subject(s)
Cyclic AMP/physiology , DNA-Binding Proteins/physiology , Melanocytes/cytology , Signal Transduction , Transcription Factors , 3T3 Cells , Animals , Cell Differentiation/drug effects , DNA-Binding Proteins/genetics , Enzyme Activation , Gene Expression Regulation , Genes, Regulator , Humans , Melanoma, Experimental , Mice , Microphthalmia-Associated Transcription Factor , Monophenol Monooxygenase/genetics , Promoter Regions, Genetic/drug effects , Transcription, Genetic/drug effects , Tumor Cells, Cultured
6.
Mol Biol Cell ; 9(6): 1367-78, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9614180

ABSTRACT

Up-regulation of the cAMP pathway by forskolin or alpha-melanocyte stimulating hormone induces melanocyte and melanoma cell differentiation characterized by stimulation of melanin synthesis and dendrite development. Here we show that forskolin-induced dendricity is associated to a disassembly of actin stress fibers. Since Rho controls actin organization, we studied the role of this guanosine triphosphate (GTP)-binding protein in cAMP-induced dendrite formation. Clostridium botulinum C3 exotransferase, which inhibits Rho, mimicked the effect of forskolin in promoting dendricity and stress fiber disruption, while the Escherichia coli toxin cytotoxic necrotizing factor-1 (CNF-1), which activates Rho and the expression of a constitutively active Rho mutant, blocked forskolin-induced dendrite outgrowth. In addition, overexpression of a constitutively active form of the Rho target p160 Rho-kinase (P160(ROCK)) prevented the dendritogenic effects of cAMP. Our results suggest that inhibition of Rho and of its target p160(ROCK) are required events for cAMP-induced dendrite outgrowth in B16 cells. Furthermore, we present evidence that Rho is involved in the regulation of melanogenesis. Indeed, Rho inactivation enhanced the cAMP stimulation of tyrosinase gene transcription and protein expression, while Rho constitutive activation impaired these cAMP-induced effects. This reveals that, in addition to controlling dendricity, Rho also participates in the regulation of melanin synthesis by cAMP.


Subject(s)
Bacterial Proteins , Botulinum Toxins , Cell Differentiation , Cyclic AMP/physiology , Escherichia coli Proteins , GTP-Binding Proteins/physiology , ADP Ribose Transferases/pharmacology , Actins/metabolism , Animals , Bacterial Toxins/pharmacology , Cell Division , Colforsin/pharmacology , Cytoskeleton/physiology , Cytotoxins/pharmacology , Dendrites , GTP-Binding Proteins/antagonists & inhibitors , Intracellular Signaling Peptides and Proteins , Melanoma, Experimental , Mice , Phenotype , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/physiology , Tumor Cells, Cultured , rho GTP-Binding Proteins , rho-Associated Kinases
7.
Biol Reprod ; 58(2): 591-9, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9475418

ABSTRACT

In the present study we report the isolation and characterization of a clonal Sertoli cell line (42GPA9) from sexually mature polyoma virus large T (PyLT) transgenic mice. The cells multiplied indefinitely and expressed large T antigen. The 42GPA9 cell line expressed biochemical features associated with normal Sertoli cells. Transferrin, sulfated glycoprotein-2, and the ligand of c-kit were detected by reverse transcription-polymerase chain reactions and Western blot analyses. Zymographic analysis indicated that the 42GPA9 cell line secreted tissue-type plasminogen activator. These cells also retained FSH receptors as suggested by their specific responsiveness to the gonadotropin (morphological and phagocytic changes, stimulation of cAMP production) and the detection of FSH receptor mRNAs. Another original aspect of the 42GPA9 cell line is its ability to form tight junctions at confluency as demonstrated by electron microscopic study and immunolocalization of the tight junction-associated protein zonula occludens 1. The 42GPA9 cell line, which has retained several important hallmarks of normal Sertoli cells, may prove useful for further studies on Sertoli cell behavior and on Sertoli-germ cell interactions in the mature testis.


Subject(s)
Polyomavirus/genetics , Sertoli Cells/physiology , Animals , Antigens, Viral, Tumor/biosynthesis , Blotting, Western , Cell Line , Clone Cells , Cyclic AMP/metabolism , Indicators and Reagents , Male , Mice , Mice, Transgenic , Microscopy, Electron , Phagocytosis/physiology , Polymerase Chain Reaction , Receptors, FSH/biosynthesis , Receptors, FSH/genetics , Sertoli Cells/metabolism , Sertoli Cells/ultrastructure , Tight Junctions/physiology , Tight Junctions/ultrastructure
8.
Mol Cell Biol ; 18(2): 694-702, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9447965

ABSTRACT

In melanocytes and in melanoma cells, cyclic AMP (cAMP)-elevating agents stimulate melanogenesis and increase the transcription of tyrosinase, the rate-limiting enzyme in melanin synthesis. However, two other enzymes, tyrosinase-related protein 1 (TRP1) and TRP2, are required for a normal melanization process leading to eumelanin synthesis. In B16 melanoma cells, we demonstrated that stimulation of melanogenesis by cAMP-elevating agents results in an increase in tyrosinase, TRP1, and TRP2 expression. cAMP, through a cAMP-dependent protein kinase pathway, stimulates TRP1 and TRP2 promoter activities in both B16 mouse melanoma cells and normal human melanocytes. Regulation of the TRP1 and TRP2 promoters by cAMP involves a M box and an E box. Further, a classical cAMP response element-like motif participates in the cAMP responsiveness of the TRP2 promoter, demonstrating that the TRP2 gene is subjected to different regulatory processes, which could account for its different expression patterns during embryonic development or under specific physiological and pathological conditions. We also found that microphthalmia, a basic helix-loop-helix transcription factor, strongly stimulates the transcriptional activities of the TRP1 and TRP2 promoters, mainly through binding to the M boxes. Additionally, we demonstrated that cAMP increases microphthalmia expression and thereby its binding to TRP1 and TRP2 M boxes. These convergent and compelling results disclose at least a part of the molecular mechanism involved in the regulation of melanogenic gene expression by cAMP and emphasize the pivotal role of microphthalmia in this process.


Subject(s)
Cyclic AMP/metabolism , DNA-Binding Proteins/metabolism , Helix-Loop-Helix Motifs , Intramolecular Oxidoreductases/genetics , Leucine Zippers , Membrane Glycoproteins , Oxidoreductases , Promoter Regions, Genetic , Proteins/genetics , Transcription Factors/metabolism , Animals , Cyclic AMP-Dependent Protein Kinases/metabolism , Gene Expression Regulation, Enzymologic , Humans , Mice , Microphthalmia-Associated Transcription Factor , Monophenol Monooxygenase/metabolism , Tumor Cells, Cultured
9.
Ann Pharm Fr ; 47(3): 169-77, 1989.
Article in French | MEDLINE | ID: mdl-2634933

ABSTRACT

Official methods for determination of ginsenosides of the French and Helvetic Pharmacopoeias have been compared with HPLC method. Sample preparation schemes used are those of monographs with conventional solvent extraction and solid phase extraction with a polar and a non-polar sorbents, respectively kieselguhr and C 18 octadecyl. Liquid-solid sample clean-up with C 18 cartridge is the most effective procedure. Prior HPLC method, an hydrolysis step of malonylginsenosides is necessary. Very selective extraction resulting in highly purified solution authorizes reliable and rapid colorimetric determination from ginseng saponosides.


Subject(s)
Chromatography, High Pressure Liquid/methods , Panax/analysis , Plants, Medicinal , Saponins/isolation & purification , Colorimetry , Plants, Medicinal/analysis
SELECTION OF CITATIONS
SEARCH DETAIL